Therapeutic Product Immunogenicity Community

 View Only
Back to discussions
Expand all | Collapse all

Join the NAM Working Group – Expanding a Cross‑Industry Community

  • 1.  Join the NAM Working Group – Expanding a Cross‑Industry Community

    Posted 4 hours ago
    The NAM Working Group has successfully launched and is actively growing into a cross‑industry, cross‑sector network connecting industry, academia, and regulators. Following a strong kickoff presentation and clearly defined scope, the group now includes representatives from multiple pharmaceutical companies as well as FDA participants.
    To support focused scientific collaboration, we have established dedicated subgroups in:
    • Immunogenicity / Immunotoxicity
    • DMPK
    The NAM Working Group is also emerging as a visible thought‑leadership forum by:
    • Sharing and discussing new NAM‑related publications
    • Supporting external scientific talks and educational sessions aligned with NAM themes and working group expertise
    Recent outreach includes setting up the upcoming PEGS Boston short course "AI-Driven Predictive Preclinical Models: Redefining the Role of Animal Testing". SC2: AI-Driven Predictive Preclinical Models: Rethinking the Role of Animal Testing
    If you're interested in contributing to scientific discussion, regulatory engagement, and the advancement of NAMs across disciplines, we welcome new members to join and shape the next phase of this growing community.
    Vibha Jawa and Pooja Khanna


    ------------------------------
    Pooja Khanna
    Senior Scientist
    Merck & Co, Inc - Rahway, NJ
    Lower Gwynedd Township PA
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------